| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Pathology,*
Surgery,
and
Oncology,
The Johns Hopkins Medical
Institutions, Baltimore, Maryland; the Department of
Pathology,§
Memorial Sloan-Kettering Cancer
Center, New York, New York; and the Department of
Pathology,¶
Wayne State University,
Detroit, Michigan
DPC4 (MADH4, SMAD4) encodes a nuclear transcription factor shown to be genetically inactivated in over one-half of conventional infiltrating ductal adenocarcinomas of the pancreas. Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas have been suggested to be distinct neoplasms with a significantly less aggressive course than conventional ductal adenocarcinomas of the pancreas, but molecular comparisons of these tumor types have previously been impaired by technical difficulties. Recently, immunohistochemical labeling for the DPC4 gene product has been shown to be an extremely sensitive and specific marker for DPC4 gene alterations in pancreatic adenocarcinomas. Therefore, we analyzed the immunohistochemical expression of Dpc4 protein in 79 IPMNs using a previously characterized monoclonal antibody. Twenty-nine of the IPMNs also had an associated infiltrating adenocarcinoma available for analysis. The labeling patterns observed were compared to those we have previously reported for conventional ductal carcinomas. All 79 of the intraductal components of the IPMNs strongly expressed Dpc4 protein. In 77 of the 79 cases (97%), the labeling was diffusely positive, and in 2 of the 79 (3%) the labeling was focally positive. Dpc4 expression was seen in 28 (97%) of the associated 29 invasive cancers. The one infiltrating carcinoma that showed loss of Dpc4 expression was associated with an intraductal component which showed focal loss of Dpc4 expression. The strong and almost universal expression of Dpc4 in IPMNs contrasts sharply with the loss of Dpc4 expression seen in approximately 30% of in situ adenocarcinomas of the pancreas (so-called pancreatic intraepithelial neoplasms, grade 3; P < 0.001) and in 55% of pancreatic duct carcinomas (P < 0.0001). Differences in Dpc4 expression between IPMNs and ductal carcinomas suggest a fundamental genetic difference in tumorigenesis, which may relate to the significantly better clinical outcomes observed for IPMNs.
This article has been cited by other articles:
 |
|
 |
|
  T. Abe, N. Fukushima, K. Brune, C. Boehm, N. Sato, H. Matsubayashi, M. Canto, G. M. Petersen, R. H. Hruban, and M. Goggins Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms Clin. Cancer Res., October 15, 2007; 13(20): 6019 - 6025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kojima, S. M. Vickers, N. V. Adsay, N. C. Jhala, H.-G. Kim, T. R. Schoeb, W. E. Grizzle, and C. A. Klug Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia Cancer Res., September 1, 2007; 67(17): 8121 - 8130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schonleben, W. Qiu, N. T. Ciau, D. J. Ho, X. Li, J. D. Allendorf, H. E. Remotti, and G. H. Su PIK3CA Mutations in Intraductal Papillary Mucinous Neoplasm/Carcinoma of the Pancreas. Clin. Cancer Res., June 15, 2006; 12(12): 3851 - 3855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Raut, K. R. Cleary, G. A. Staerkel, J. L. Abbruzzese, R. A. Wolff, J. H. Lee, J.-N. Vauthey, J. E. Lee, P. W. T. Pisters, and D. B. Evans Intraductal Papillary Mucinous Neoplasms of the Pancreas: Effect of Invasion and Pancreatic Margin Status on Recurrence and Survival Ann. Surg. Oncol., April 1, 2006; 13(4): 582 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kawamoto, K. M. Horton, L. P. Lawler, R. H. Hruban, and E. K. Fishman Intraductal Papillary Mucinous Neoplasm of the Pancreas: Can Benign Lesions Be Differentiated from Malignant Lesions with Multidetector CT? RadioGraphics, November 1, 2005; 25(6): 1451 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sato, H. Matsubayashi, T. Abe, N. Fukushima, and M. Goggins Epigenetic Down-Regulation of CDKN1C/p57KIP2 in Pancreatic Ductal Neoplasms Identified by Gene Expression Profiling Clin. Cancer Res., July 1, 2005; 11(13): 4681 - 4688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Abdelrahim, R. Smith III, R. Burghardt, and S. Safe Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells Cancer Res., September 15, 2004; 64(18): 6740 - 6749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takahashi, T. Oda, T. Hasebe, Y. Aoyagi, T. Kinoshita, M. Konishi, T. Nakagohri, K. Inoue, S. Takahashi, H. Kawahira, et al. Biologically Different Subgroups of Invasive Ductal Carcinoma of the Pancreas: Dpc4 Status According to the Ratio of Intraductal Carcinoma Components Clin. Cancer Res., June 1, 2004; 10(11): 3772 - 3779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sato, N. Fukushima, A. Maitra, C. A. Iacobuzio-Donahue, N. T. van Heek, J. L. Cameron, C. J. Yeo, R. H. Hruban, and M. Goggins Gene Expression Profiling Identifies Genes Associated with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas Am. J. Pathol., March 1, 2004; 164(3): 903 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. House, M. Guo, C. Iacobuzio-Donahue, and J. G. Herman Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas Carcinogenesis, February 1, 2003; 24(2): 193 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A V Biankin, S A Biankin, J G Kench, A L Morey, C-S Lee, D R Head, R P Eckstein, T B Hugh, S M Henshall, and R L Sutherland Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma Gut, June 1, 2002; 50(6): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Han, D. J. Bearss, L. W. Browne, R. Calaluce, R. B. Nagle, and D. D. Von Hoff Identification of Differentially Expressed Genes in Pancreatic Cancer Cells Using cDNA Microarray Cancer Res., May 1, 2002; 62(10): 2890 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Terris, E. Blaveri, T. Crnogorac-Jurcevic, M. Jones, E. Missiaglia, P. Ruszniewski, A. Sauvanet, and N. R. Lemoine Characterization of Gene Expression Profiles in Intraductal Papillary-Mucinous Tumors of the Pancreas Am. J. Pathol., May 1, 2002; 160(5): 1745 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Komori, O. Ishikawa, H. Ohigashi, T. Yamada, Y. Sasaki, S. Imaoka, A. Nakaizumi, H. Uehara, S. Tanaka, Y. Mano, et al. Invasive Ductal Adenocarcinoma of the Remnant Pancreatic Body 9 Years after Resection of an Intraductal Papillary-Mucinous Carcinoma of the Pancreatic Head: a Case Report and Comparison of DNA Sequence in K-ras Gene Mutation Jpn. J. Clin. Oncol., April 1, 2002; 32(4): 146 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sato, C. Rosty, M. Jansen, N. Fukushima, T. Ueki, C. J. Yeo, J. L. Cameron, C. A. Iacobuzio-Donahue, R. H. Hruban, and M. Goggins STK11/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas Am. J. Pathol., December 1, 2001; 159(6): 2017 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tascilar, H. G. Skinner, C. Rosty, T. Sohn, R. E. Wilentz, G. J. A. Offerhaus, V. Adsay, R. A. Abrams, J. L. Cameron, S. E. Kern, et al. The SMAD4 Protein and Prognosis of Pancreatic Ductal Adenocarcinoma Clin. Cancer Res., December 1, 2001; 7(12): 4115 - 4121. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
